Amylyx Pharmaceuticals Inc (AMLX)
1.81
-0.09
(-4.74%)
USD |
NASDAQ |
Apr 30, 16:00
1.82
+0.01
(+0.55%)
After-Hours: 06:29
Amylyx Pharmaceuticals Profit Margin (Quarterly): 4.36% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 4.36% |
| September 30, 2023 | 20.35% |
| June 30, 2023 | 22.48% |
| Date | Value |
|---|---|
| March 31, 2023 | 2.20% |
| December 31, 2022 | -195.1% |
| September 30, 2022 | -15.58K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-15.58K%
Minimum
Sep 2022
22.48%
Maximum
Jun 2023
-2.62K%
Average
3.28%
Median
Profit Margin (Quarterly) Benchmarks
| Cassava Sciences Inc | -- |
| iRhythm Technologies Inc | -29.20% |
| Bristol-Myers Squibb Co | -100.4% |
| Moderna Inc | 7.71% |
| ACADIA Pharmaceuticals Inc | 19.82% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 12.75% |
| Return on Assets | 11.01% |
| Return on Invested Capital | 12.75% |
| Gross Profit Margin (Quarterly) | 91.37% |
| Operating Margin (Quarterly) | 1.78% |
| Return on Net Operating Assets | 84.79% |